Cost cutting, new drugs boost Amgen shares
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”27-04-2014″ enddate=”27-10-2014″ width=”300″ height=”245″] Cost cutting moves and new drugs are starting to pay off for Amgen Inc., as the biotech giant raised earnings guidance after a stronger-than-expected third quarter. The company said Oct. 27 that strong demand for its white blood cell booster, Neulasta, and increased sales of newer Read More →
Summers exits Ventura County Chamber of Commerce
The Ventura County Chamber of Commerce Board of Directors has announced that President and CEO Edward Summers is resigning. Summers’ resignation was effective on Oct. 24. Stepping into the position on an interim basis is current Vice Chair of Business Development Matthew Graczyk as the chamber launches the effort to find a new CEO. “We Read More →
Nasdaq delisting in sight for Ceres
Ceres, Inc., an agricultural biotechnology company that sells seeds for producing renewable bioenergy feedstocks, is delisting from the Nasdaq after the company continued to fail to meet the minimum bid price requirement of $1.00. The company was notified on April 28, that it no longer met the criteria for listing and in anticipation of not Read More →
Ryland shares gain on housing market performance
[wikichart align=”right” ticker=”NYSE:RYL” showannotations=”true” livequote=”true” startdate=”24-04-2014″ enddate=”24-10-2014″ width=”300″ height=”245″] Based in part on a 7.2 percent increase in third-quarter orders for new units, Westlake Village-based national homebuilder Ryland Group was trading higher Thursday after projected earnings beat Wall Street analyst expectations. Shares of Ryland Group closed at $35.78 on Oct. 23. The company reported a Read More →
Munger’s $65M gift raises the bar for UCSB
Munger’s gift outpaces a $50 million gift by Oracle Corp. Vice Chairman Jeff Henley to fund UCSB’s research into energy efficiency and other science programs.
